fluoxetine has been researched along with Hypoventilation in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Hypoventilation: A reduction in the amount of air entering the pulmonary alveoli.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kopelman, PG | 1 |
Elliott, MW | 1 |
Simonds, A | 1 |
Cramer, D | 1 |
Ward, S | 1 |
Wedzicha, JA | 1 |
1 trial available for fluoxetine and Hypoventilation
Article | Year |
---|---|
Short-term use of fluoxetine in asymptomatic obese subjects with sleep-related hypoventilation.
Topics: Adult; Apnea; Double-Blind Method; Female; Fluoxetine; Humans; Hypoventilation; Male; Middle Aged; O | 1992 |